Search

everythinglearnresearchcommunity

for

Search:↓

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Chemical exposure may contribute to the rise in atopic diseases and needs more research.

Atopic dermatitis in kids with alopecia areata can predict poor response to topical immunotherapy.

Pregnancy can trigger follicular mucinosis, which may resolve after delivery.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.

Spironolactone and clascoterone are promising acne treatments with fewer side effects.

People with non-scarring hair loss often have lower vitamin D levels than those without hair loss.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

Swiss experts recommend specific guidelines for diagnosing and treating hidradenitis suppurativa to improve patient care.

Imbalance in scalp bacteria can affect hair and scalp health, potentially leading to conditions like hair loss, psoriasis, and dandruff.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Alopecia areata does not affect areas with psoriasis plaques.

Scalp psoriasis features reversible hair loss and specific immune activation, with no significant hair follicle damage.

Less than a quarter of alopecia areata cases were unusual forms or had paradoxical regrowth.

A 6-year-old girl with alopecia universalis regrew most of her hair after treatment with simvastatin/ezetimibe, minoxidil, and prednisolone.

Patients using social media have mixed feelings about alopecia treatments, noting hair growth but also frustration with treatment recurrence.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.

Low vitamin D levels are linked to more skin problems.

Early and proper treatment is crucial for children with allergic conjunctivitis to avoid complications.

Dupilumab for skin problems might reactivate hair loss in some patients.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Autoimmune and metabolic issues are linked, and treating one may worsen another.

COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

A patient got a skin reaction on their hands and feet after using secukinumab for psoriasis.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.